Cooper WA - Search Results

1

Fluorescent In Situ Hybridization in Surgical Pathology Practice.

Gupta R, Cooper WA, Selinger C, Mahar A, Anderson L, Buckland ME, O'Toole SA. Gupta R, et al. Among authors: cooper wa. Adv Anat Pathol. 2018 Jul;25(4):223-237. doi: 10.1097/PAP.0000000000000194. Adv Anat Pathol. 2018. PMID: 29727321 Review.

2

What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.

Cooper WA, O'toole S, Boyer M, Horvath L, Mahar A. Cooper WA, et al. Pathology. 2011 Feb;43(2):103-15. doi: 10.1097/PAT.0b013e328342629d. Pathology. 2011. PMID: 21233671 Review.

3

Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.

Selinger CI, Cooper WA, Al-Sohaily S, Mladenova DN, Pangon L, Kennedy CW, McCaughan BC, Stirzaker C, Kohonen-Corish MR. Selinger CI, et al. Among authors: cooper wa. J Thorac Oncol. 2011 Jul;6(7):1179-89. doi: 10.1097/JTO.0b013e31821b4ce0. J Thorac Oncol. 2011. PMID: 21597389 Free article.

4

Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.

Poursoltan P, Currey N, Pangon L, van Kralingen C, Selinger CI, Mahar A, Cooper WA, Kennedy CW, McCaughan BC, Trent R, Kohonen-Corish MR. Poursoltan P, et al. Among authors: cooper wa. Lung Cancer. 2012 Aug;77(2):272-6. doi: 10.1016/j.lungcan.2012.04.001. Epub 2012 Apr 26. Lung Cancer. 2012. PMID: 22542170

5

Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.

Yip PY, Yu B, Cooper WA, Selinger CI, Ng CC, Kennedy CW, Kohonen-Corish MR, McCaughan BC, Trent RJ, Boyer MJ, Kench JG, Horvath LG, O'Toole SA. Yip PY, et al. Among authors: cooper wa. J Thorac Oncol. 2013 Apr;8(4):408-14. doi: 10.1097/JTO.0b013e318283558e. J Thorac Oncol. 2013. PMID: 23392229 Free article.

6

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization.

Selinger CI, Rogers TM, Russell PA, O'Toole S, Yip P, Wright GM, Wainer Z, Horvath LG, Boyer M, McCaughan B, Kohonen-Corish MR, Fox S, Cooper WA, Solomon B. Selinger CI, et al. Among authors: cooper wa. Mod Pathol. 2013 Dec;26(12):1545-53. doi: 10.1038/modpathol.2013.87. Epub 2013 Jun 7. Mod Pathol. 2013. PMID: 23743928 Free article.

7

EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.

Cooper WA, Yu B, Yip PY, Ng CC, Lum T, Farzin M, Trent RJ, Mercorella B, Clarkson A, Kohonen-Corish MR, Horvath LG, Kench JG, McCaughan B, Gill AJ, O'Toole SA. Cooper WA, et al. J Clin Pathol. 2013 Sep;66(9):744-8. doi: 10.1136/jclinpath-2013-201607. Epub 2013 Jun 11. J Clin Pathol. 2013. PMID: 23757037

8

Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.

Tran TN, Selinger CI, Kohonen-Corish MRJ, McCaughan BC, Kennedy CW, O'Toole SA, Cooper WA. Tran TN, et al. Among authors: cooper wa. Lung Cancer. 2013 Sep;81(3):462-467. doi: 10.1016/j.lungcan.2013.05.015. Epub 2013 Jun 24. Lung Cancer. 2013. PMID: 23806793

9

Pulmonary pathology: new updates.

Cooper WA, Roberts F. Cooper WA, et al. J Clin Pathol. 2013 Oct;66(10):831. doi: 10.1136/jclinpath-2013-201898. J Clin Pathol. 2013. PMID: 24067550 No abstract available.

10

Molecular biology of lung cancer.

Cooper WA, Lam DC, O'Toole SA, Minna JD. Cooper WA, et al. J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S479-90. doi: 10.3978/j.issn.2072-1439.2013.08.03. J Thorac Dis. 2013. PMID: 24163741 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page